Similar articles

• The respiratory, circulatory, and narcotic antagonistic effects of nalorphine, levallorphan, and naloxone in anaesthetized subjects.

  Foldes FF, Duncalf D, Kuwabara S. Foldes FF, et al. Can Anaesth Soc J. 1969 Mar;16(2):151-61. doi: 10.1007/BF03005795. Can Anaesth Soc J. 1969. PMID: 5773493 No abstract available.
• COMPARATIVE STUDIES WITH NARCOTICS AND NARCOTIC ANTAGONISTS IN MAN.

  FOLDES FF, TORDA TA. FOLDES FF, et al. Acta Anaesthesiol Scand. 1965;9:121-38. doi: 10.1111/j.1399-6576.1965.tb00499.x. Acta Anaesthesiol Scand. 1965. PMID: 14319086 No abstract available.
• USE OF WRITHING TEST FOR EVALUATING ANALGESIC ACTIVITY OF NARCOTIC ANTAGONISTS.

  BLUMBERG H, WOLF PS, DAYTON HB. BLUMBERG H, et al. Proc Soc Exp Biol Med. 1965 Mar;118:763-6. doi: 10.3181/00379727-118-29963. Proc Soc Exp Biol Med. 1965. PMID: 14268686 No abstract available.
• Assays for narcotic antagonist activity in rodents.

  Pierson AK. Pierson AK. Adv Biochem Psychopharmacol. 1973;8(0):245-61. Adv Biochem Psychopharmacol. 1973. PMID: 4152786 Review. No abstract available.
• THE CLINICAL EVALUATION OF MORPHINE AND ITS SUBSTITUTES AS ANALGESICS.

  LASAGNA L. LASAGNA L. Pharmacol Rev. 1964 Mar;16:47-83. Pharmacol Rev. 1964. PMID: 14165239 Review. No abstract available.